An association between central serous chorioretinopathy and gastroesophageal reflux disease.

Mansuetta, Cheri C; Mason, John O; Swanner, Jason; Feist, Richard M; White, Milton F; Thomley, Martin L; McGwin, Gerald; Emond, Tracy L · Am J Ophthalmol · 2004

case_control · Level III

Where this comes from

Abstract

To explore a clinically observed association between central serous chorioretinopathy (CSC) and gastroesophageal reflux disease (GERD) DESIGN: A retrospective case-control study. Sixty-nine consecutive patients diagnosed with CSC were compared with a control group of 55 non-CSC patients. The records of 69 patients with CSC were retrospectively reviewed and compared with the records of 55 controls. All patients and controls were examined in a referral setting. Patients with CSC were significantly more likely to have GERD compared with controls (odds ratio 6.05; 95% confidence interval 2.14-17.11; P =.0003). Central serous chorioretinopathy patients were also more likely than controls to have used oral corticosteroid medications (odds ratio 16.30; 95% confidence interval 2.09-127.33; P =.0006) and antacid/antireflux medications (odds ratio 15.00; 95% confidence interval 1.91-117.58; P =.001). This study identifies an association between CSC and GERD. There are biochemical factors common to both diseases that support this association, giving further insight into the pathogenesis of CSC.

Medical subject headings